• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Troleandomycin
Date Designated:  09/21/1989
Orphan Designation:  Treatment of severe steroid-requiring asthma.
Orphan Designation Status:  Designated/Withdrawn
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Szefler, Stanley M. M.D.
National Jewish Center for Immunology and Respirat
1400 Jackson Street
Denver, Colorado 80206
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.